Kontrastli Mamografi Görüntülerinde Kitlelerin Şekil ve Birinci Dereceden Istatistiksel Özniteliklere Dayali Siniflandirmasi
Erişim
info:eu-repo/semantics/restrictedAccessTarih
2023Yazar
Kobya, Mehmet EminTüre, Hayati
Doǧan, Ramazan Özgür
Kayikçioǧlu, Temel
Teymur, Aykut
Kul, Sibel
Erişim
info:eu-repo/semantics/restrictedAccessÜst veri
Tüm öğe kaydını gösterKünye
M. E. Kobya, H. Türe, R. Ö. Doğan, T. Kayikçioğlu, A. Teymur and S. Kul, "Kontrastlı Mamografi Görüntülerinde Kitlelerin Şekil ve Birinci Dereceden İstatistiksel Özniteliklere Dayalı Sınıflandırması," 2023 31st Signal Processing and Communications Applications Conference (SIU), Istanbul, Turkiye, 2023, pp. 1-4, doi: 10.1109/SIU59756.2023.10223839.Özet
Mammography is a valuable tool in the diagnosis and staging of primary breast cancer. Contrast-enhanced mammography (CEM) combines an iodinated contrast agent with traditional mammography to increase diagnostic accuracy, especially in women with more dense parenchymal background patterns. In this study, a Decision Support System (DSS) is proposed that classifies masses using radiomic features obtained from masks of benign and malignant masses in images obtained with the CEM technique. An open-access database containing 2006 CEM images was used in this study. Radiomic features obtained from these images were used to identify differences between benign and malignant masses. The DSS uses these features to classify masses using a decision tree algorithm. This study highlights the importance of the use of iodinated contrast agents to improve diagnostic accuracy in women with more dense parenchymal background patterns. Additionally, it emphasizes the potential benefits of a DSS, in combination with radiomic features, in the diagnosis and staging of breast cancer. In conclusion, this study demonstrates that the use of radiomic features in mammography images obtained with the CEM technique is an effective way to classify benign and malignant masses.The use of this technology could be an important tool in the early diagnosis and accurate classification of breast cancer. © 2023 IEEE.